December 2, 2021

Volume XI, Number 336

Advertisement
Advertisement

December 01, 2021

Subscribe to Latest Legal News and Analysis

November 30, 2021

Subscribe to Latest Legal News and Analysis

November 29, 2021

Subscribe to Latest Legal News and Analysis

ANSES Reiterates Recommendation to Restrict Use of Products Containing Nanomaterials “That Are of Little Benefit to the Population”

On June 3, 2021, the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) published an interview with Aurélie Niaudet, who is in charge of assessing the risks associated with physical agents. Niaudet states that nanomaterials have novel properties that “are highly sought after and increasingly exploited, but can also induce specific types of behavior when interacting with humans or the environment.” After the human body is exposed, “there is then the question of the distribution and possible accumulation of these nanomaterials in the various organs.” According to Niaudet, “assessing the risks associated with nanomaterials involves three steps: agreeing on criteria for defining them, describing the main types of exposure, and understanding their behavior and effects.” As reported in our previous blog items, ANSES’s work on nanomaterials has addressed titanium dioxide and nano silver, and recently included a review of the presence of engineered nanomaterials in food. ANSES also manages the R-Nano register and published an analysis in 2020 that “highlighted the poor quality of the reported data and led ANSES to issue recommendations to declaring companies and to the ministries to consolidate this register and increase its usefulness.” ANSES also coordinates the National Research Program for Environmental and Occupational Health, funding research on the effects and environmental fate of nanomaterials, as well as on monitoring population exposure.

To protect people, Niaudet recommends that, in addition to strengthening the regulatory framework, “it is also important to limit exposure of the population and the environment as a precautionary measure, by choosing safe products that are equally effective but free of nanomaterials.” Niaudet states that ANSES “reiterates its recommendation to restrict the use of products containing nanomaterials that are of little benefit to the population.”

©2021 Bergeson & Campbell, P.C.National Law Review, Volume XI, Number 158
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether...

202-557-3801
Carla Hutto, Bergeson Campbell PC environmental law regulatory analyst,Toxic Substances Control Act law attorney
Regulatory Analyst

Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client...

202-557-3809
Advertisement
Advertisement
Advertisement